Literature DB >> 2564831

Variable receptor affinity hypothesis.

J A Bevan1, R D Bevan, S M Shreeve.   

Abstract

Measurements of the contractile response to norepinephrine (NE) of a variety of arteries of three mammalian species that are commonly used in the laboratory provide evidence that tissue sensitivity and affinity of the alpha 1-adrenoceptor for NE covary over a range of several orders of magnitude. The quantitative relationship suggests that variation in affinity can, to a great extent, account for the variation in sensitivity found in a number of circumstances. Furthermore, it is argued that the variation in affinity appears to be continuous and thus does not provide a basis for receptor type subdivision. There is also evidence that adrenergic antagonist affinity can vary significantly in tissues. The factors that might account for this variation include differences in receptor chemical structure, in the local membrane microenvironment, and in a number of intracellular processes. A hypothesis of variable receptor affinity has been proposed. If it is correct, then variation in receptor affinity is an important functionally relevant variable that could account for selectivity of tissue responses to circulating hormones and may represent a mechanism of change in the intact organism and in disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564831     DOI: 10.1096/fasebj.3.6.2564831

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

Review 1.  Drugs and receptors. An overview of the current state of knowledge.

Authors:  T Kenakin
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

2.  Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.

Authors:  R M Eglen; W W Montgomery; R L Whiting
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

3.  The relationship between receptor-effector unit heterogeneity and the shape of the concentration-effect profile: pharmacodynamic implications.

Authors:  A Hoffman; A Goldberg
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

4.  Comparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling.

Authors:  K N Klotz; H Vogt; H Tawfik-Schlieper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

5.  Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries.

Authors:  P H Van der Graaf; P R Saxena; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

6.  Regulation of beta-adrenoceptor properties and the lipid milieu in heart muscle membranes during stress.

Authors:  S Gudbjarnason; V E Benediktsdóttir
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

7.  Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues.

Authors:  G J Christ; S Maayani; M Valcic; A Melman
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

8.  Pore formation in lipid bilayer membranes made of phosphatidylinositol and oxidized cholesterol followed by means of alternating current.

Authors:  E Gallucci; S Micelli; G Monticelli
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

9.  Metabotropic glutamate receptor analogues inhibit p[NH]ppG-stimulated phospholipase C activity in bovine brain coated vesicles: involvement of a pertussis toxin-sensitive G-protein.

Authors:  M Martín; J M Sanz; M Ros; A Cubero
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.